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Objectives . Because endothelial dysfunction is an early e lent in
athe enesis, we aimed to determine whether endothelial func-
tion is normal or unpaired in the systemic arteries of children with
homozygous homocystinuria or in those of heterozygous adults, or
Background. homocystinuria Is strongly associated with pre
.
mature vascular d in homozygotes, and even heterozygotes
have been shown to be at increased risk from early atherosclerosis
is with hyperhomocystinemia.
Methods. We conducted noninvasive studies on the superficial
femoral or brachial arteries of 9 children aged 4 to 17 years (me
11) with homozygous homocystinuria and on the brachial arteries
of 14 obligate heterozygote parents a 33 to 49 years (mean 41) .
Each subject was matched with two control subjects . Using high
resolution ultrasound, we measured vessel diameter at rest, during
reactive hyperemia (with flow Increase causing endothelium-
dependent dilation) and after sublingual administration of vitro.
rin (an endothelium-independent vasodilator) .
Classic homocystinuria is an autosomal recessive disorder
caused by a deficiency of cystathionine beta-synthase
. Ho-
mozygotes commonly have ocular, skeletal and neurobehav-
ioral complications of the disease and are at high risk for
premature atherosclerosis and thrombosis (1,2) . Homocys-
teine is a highly reactive amino acid and is generally thought
to initiate premature atherosclerosis by damaging endothe-
lial cells (3,4) . Endothelial dysfunction may then result in
abnormal reactions between the vessel wall and platelets,
neutrophils and macrophages, and thereby contribute to the
atherogenic and thrombogenic processes (5)
. The age at
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Results . Flow-mediated dilation was observed In the control
children (9 ± 0 .6%, range 6% to 14%) but was impaired in the
children with homocystinuria (2 .8 ± 0.7%, range 0% to 7%, p
0.0001). In contrast, nitroglycerin-mediated dilation was similar
fit both groups (15.7 ± 1 .6% vs. 13,1 ± 1.2%, p
: 0
.27),
indicating that the impaired flow-mediated dilation is secondary to
endothelial dysfunction. In the heterozygous parents, both flow-
mediated dilation and nitroglycerin responses (6 .3 ± 0.9%, 17 1
.4%, respectively) were similar to control values (6 .8 t 0.7%,
20.7±1.7%,p>0.10) .
Conclusions. Children with homozygous homocystinuria had
Impaired endothelial function in the systemic arteries as early as
4 years of age, representing an early event in their premature
vascular disease . However, endothelial function was preserved in
the heterozygous adults .
(J . to Call Cardial 1993;22 :854-8)
which endothelial dysfunction is demonstrable in the sys-
temic arteries of chi"dren homozygous for homocystinuria is
not known .
Recent data have suggested that milder hyperhomo-
cystinemia, usually associated with the heterozygous state,
may be an independent risk factor for atherosclerosis (6-8) .
Although up to 30% of patients with premature vascular
disease may have hyperhomocyst(e)inemia (9,10), the inci-
dence of myocardial infarction and stroke in a group of
subjects with heterozygous homocystinuria has been shown
to be similar to that in control subjects (11) . The question
whether heterozygotes for homocystinuria are at increased
risk for atherosclerosis is important because the prevalence
of heterozygosity is -1%® to 2% of the population (7) . The
risk for such patients is not yet known and, furthermore, the
mechanism whereby vascular damage may occur is not
established .
A noninvasive method to study endothelial function in
human systemic arteries has recently been developed and
applied to document endothelial dysfunction in children and
adults at increased risk for atherosclerosis (12) . In arteries
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lined by healthy endothelium, increased flow causes dilation
of the vessel (13,14) through release of endothelium-derived
relaxing factor (15) . This mechanism fails with endothelial
damage (16,17) . We have applied this method to study
endothelial function in patients with homocystinuria to in-
vestigate at what age abnormalities in vascular physiology
might be detectable in homozygous children and whether
endothelial dysfunction is demonstrable in their heterozy-
gous parents .
Methods
Suklects, The study group comprised 9 children with
homozygous homocystinuria due to cystathionine beta
synthase deficiency, including two sets of siblings, and 14
obligate heterozygote parents of these children . Each sub-
ject was matched with two control subjects of similar age,
gender, smoking history, cholesterol level, vessel size and
vessel studied ; all 46 control subjects were chosen from a
data base of >300 subjects studied with this technique . All
studies were approved by the institution's Committee on
Ethical Practice .
Study design . The diameter of the target artery was
measured from two-dimensional ultrasound images, using a
7.0-MHz linear array transducer and a standard Acuson
128XP/10 system . In all studies, scans were taken when
subjects were at rest, during reactive hyperemia, again at
rest and after administrations of sublingual nitroglycerin . The
superficial femoral artery was studied in the six children in
whom the diameter of this vessel was !s :6.0 mm ; the brachial
artery was studied in the other children and the adult
subjects . The study design and technique for scan acquisi-
tion are described in detail elsewhere (12) .
Data analysis . Vessel diameter was measured as de-
scribed elsewhere (12), by two observers who had no knowl-
edge of the condition of the subject or the stage of the
experiment. To assess the accuracy of detecting small
changes in vessel diameter, a phantom was constructed
containing 10 "arteries" located 10 mm below the phantom
surface. These "arteries," which measured (in mm) 2 .8, 3 .0,
3 .2, 3 .4, 3 .6, 4 .0, 4 .1, 4 .2, 4 .3 and 4 .4, mimicking the brachial
artery diameter ranges of normal male and female subjects,
were arranged in random order. Two operators scanned each
artery three times, using the same instrument settings used
during the clinical studies and recording images on super-
VHS videotape for later off-line analysis . Four independent
observers who were unaware of the characteristics of the
phantom then analyzed each scan on three occasions in
random order. The three measurements made for each scan
by each observer were averaged and rounded to the nearest
0.1 turn . Therefore, the phantom offers four pairs of "arter-
ies" whose diameters differ by 0 .1 mm and seven pairs
whose diameters differ by 0 .2 mm. In 96 observations, a
diameter difference of 0.1 mm was estimated accurately (as
0.1 mm) on 52% of occasions and was underestimated or
overestimated by 0.1 mm on 21% and 27% of occasions,
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Table 1 . Arterial Studies in Auniocystinuric and Control Children
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Data are presented as mean value ± SEM or number [%] of children .
FMD = flow-mediated dilation ; HC = homozygous homorcystinuria ; NTG
nitroglycerin-induced dilation .
respectively . In 168 observations, a diameter difference of
0.2 mm was estimated accurately on 67% of occasions, and
was underestimated or overestimated by 0 .1 mm on 17% and
16% of occasions, respectively . The mean error for all
measurements was <0.05 mm, and no estimate of diameter
difference was >0 .1 mm in error .
Blood chemistry determinations. The concentration of
plasma and urine amino acids (including free homocystine)
was measured by standard liquid column chromatography .
Total plasma homocystine was measured by high perfor-
mance liquid chromatography by a modification of the
method of Ueland et al . (18) .
Statistics . Descriptive statistics are expressed as mean
value ± SEM. The control groups of children and adults
were compared with the children who had homozygous
homocystinuria and their parents, respectively, using two-
sample i tests . The relation between variables was assessed
by linear regression analysis . Statistical significance was
inferred at a p value < 015 .
Results
Children with homocystinuria. In these children, the age
at diagnosis was 4 months to 7 .5 years (mean 4 years) and the
age at time of study was 4 to 17 years (mean 11) (Table 1)
. Of
the nine children, seven (78%) had lens dislocation and four
(44%a) were at a special school because of mental retardation
.
Eight were taking a low protein diet, six were taking pyri-
doxine, seven were prescribed betaine and all were taking
folic acid supplements . At the time of study, the total plasma
homocystine level was raised in all patients (38 to
104 pmollfiter, mean 63 ; normal range 7 to 19) and urinary
homocystine was 2 to 62 jAmol/mmol creatinine (mean 11,
undetectable in normal subjects) . Total plasma cholesterol
was 4.1 i: 0 .4 mmol/liter (range 2 .7-6 .3) .
No children had symptoms or signs of vascular disease or
ultrasound evidence of arterial narrowing or plaque forma-
tion in the vessel studied . Flow-mediated dilation was 2
.8 ±
0.7% (range 1% to 7%) ; the degree of flow-mediated dilation
was not related to total plasma homocystine (r = 0
.04),
Children
With tit:
in = 9)
Control
Children
(n = 18)
p Value
Age Qr) 10 .9 ± 1 .3 12 .1 i 0 .7 0 .36
Male (no . 171) 31331 61331
11
.0
Chalesterol (mmol/liter) 4 .1 ± 0.4 4 .2 ± 0 .2 0.74
Vessel size (mm) 4 .0 ± 0 .3 4 .2 ± 0 .2 0.45
FMD M 2.8¢0.7 9.0±0.6 <0. I I I
NTG (%) 13 .1
	
1.2 15 .7 1 .6 0.27
Flow at rest (ml/min) 219 42 204 34 0.78
% hyperemia 349 25 391 49 0.55
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Figure
t .
Flow-mediated dilation (FMD) in children with homo-
cystinuria (HC) and in control children
. Horizontal lines indicate
group means .
cholesterol levels (r - 0.08) or age at diagnosis (r = -0
.11) .
Dilation after nitroglycerin administration was 13 .1 ± 1 .2%
(range 6% to 161%) . Flow-mediated dilation of 5% in the
femoral artery was recorded in the youngest patient . This
patient was diagnosed at 4 months of age because of an older
sibling with the disease and had good metabolic control with
no ocular or neurobehavioral complications . This was th .l
best response for a femoral vessel in the group with homo-
cystinuria but still below the range of values found in the
control children
Control children . In the 18 control children, flow-
mediated dilation was 9 t 0 .6% (range 6% to 12%, p <
0.0001 compared with that in children who had homocys-
tinuria, Table 1, Figure 1) . Dilation after nitroglycerin was
15.7 ± 1 .6% (range 110% to 24%, p o (0 .27) . Baseline flow and
degree of reactive hyperemia were similar between the
control children and children with homocystinuria . There-
fore, flow-mediated dilation was impaired in the children
with homocystinuria compared with that in control subjects,
whereas the response to nitroglycerin was similar in the two
group& This finding is consistent with endothelial dysfunc-
tion in the children with homocystinuria .
Obligate haterozygotes, homocystinuria . This group com-
prised 14 parents (from seven families studied) who under-
went vascular studies and were clinically well . Their age
ranged from 34 to 49 years (mean 41) . Free plasma homo-
cystine was undetectable and plasma methionine levels were
normal in all 14 subjects, all of whom were consuming a
normal diet. No subject had hypertension or a family history
of premature vascular disease ; cholesterol levels were 4 .4 t
o
7.2 mmol/liter (mean 5 .6). Four (29%) of 14 were current
smokers and 2 were former smokers. Flow-mediated dilation
was 6
.3 t 0.9% (range 1% to 13%) and dilation after
nitroglycerin administration was 17 ± 1.4% (range 9(yo to
27%) .
ConW adults . Each obligate heterozygote was matched
with two control adults of similar age, gender, cholesterol
level, smoking history and vessel size (Table 2) . In the
Data are expressed w, mean value z SEM or number 1%] of adults .
Abbreviations as in'fable 1 .
control adults, flow-mediated dilation was 6 .8 ± 0.7% (range
0% to 13% p = (168) and nitroglycerin-induced dilation was
20.7 ± 1 .7% (range 7% to 34%, p -- 0.17) (Fig. 2 and 3) . Flow
values at rest and the degree of reactive hyperemia were
similar in the two adult groups .
Discussion
In children with homocystinuria, endothelial function is
impaired as early as 4 years of age, before clinical or
anatomic evidence of atherosclerosis occurs . In contrast, the
endothelial-dependent responses of an adult group of obli-
gate heterozygotes are similar to those of control subjects,
suggesting that mild impairment of homocystine metabolism
may not cause important endothelial damage .
Homozygous children . Children with homozygous homo-
cystinuria we at risk tot ,rvcrc premature vascular disease
(1,2) . Marked hyperhomocystinemia is found in homozy-
gotes and is directly toxic to the endothelium (3,4), induces
smooth muscle proliferation (3), potentiates the auto-
oxidation of low density lipoprotein cholesterol (19,20) and
promotes thrombosis (21,22). Endothelial dysfunction has
been demonstrated in adults with established coronary ath-
FiLpire 2 . Flow-mediated dilation (FMD) in adults heterozygous for
homocystinuria (HC) and control adults . Horizontal lines indicate
group means .
FMD %
15 1
to 1
5 1
0
I - _=
. - NS	
0
HC
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Control
FMD
151
1o
% Table 2
. Arterial Studies in Obligate Heterozygotes for
Honiocystinuda and Adult Control Subjects
F___
P
Parents of
Children With HC
(n = 14)
Control
Adults
(n = 28) p Value
Age (yr) 41 .2 ± 1 .3 40 .4 ± 1 .0 0 .66
6
Male (no . 1%]) 7 [50%1 14 [50%] 1 .0
Cholesterol (mmol/liter) 5.6±0 .3 4.9±02 0.03
5 i Vessel size (mm) 3.9±0 .2 3 .7 ± 0.1 0 .32
FMD (%) 6.3±0 .9 68±0.7 0 .68
NTG (%) 17±1 .4 20 .7 ± 1 .7 0 .17
0
I
Flow at rest (ml/min) 165 t 28 123 ± II 0 .10
HC Control % hyperemia
425 ± 56 459 ± 36 0 .60
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Figure 3. Scans from the brachial artery of
a control subject, showing dilation in re-
sponse to both increased flow and to nitro-
glyceiiii, Stale no alvLaZ5 to the left of each
frame are 5 mm apart .
erosclerosis (23), but it is also present as an early event in
atherogenesis (24), which
precedes
plaque formation in
animal models of the disease (25) . Vie (12) have previously
shown that children with familial hypercholesterolemia,
also at risk for premature atherosclerosis, have evidence
of endothelial dysfunction as early as the I st decade of life .
The current study is the first to examine vascular physiology
in homocystinuria and demonstrates that children homozy-
gous for this disease also have endothelial damage in early
life, despite appropriate medical management at a young
age .
Heterozygous adults. When groups with premature pe-
ripheral, cerebral and coronary artery disease have been
studied, about one third have been shown to have mild
hyperhomocystinemia after a methionine load, and most of
these subjects were heterozygous for cystathionine synthase
deficiency (6,7) . This has led some investigators to propose
that heterozygotes are at increased risk for premature ath-
erosclerosis and to cite hyperhomocystinemia as an indepen-
dent risk factor (26,Z7) . However, few studies have exam-
ined a group of heterozygotes to assess the frequency of
premature vascular disease . A survey of > 1,000 parents and
grandparents of children with severe cystathionine synthase
deficiency failed to demonstrate a significant increase in the
incidence of premature vascular disease (11) . Of 20 such
heterozygotes, 5 1 was likely to have an adverse vascular
event by the age of 50 years . These results are consistent
with our study of obligate heterozygotes with low plasma
homocystine levels (without methionine loading), whose
systemic arterial endothelial and smooth muscle physiology
were similar to those of control subjects despite slightly
higher cholesterol levels in the heterozygote group . There-
fore, any increased risk of atherosclerosis in heterozygotes
may not be mediated through abnormal homocystinemia and
may be due to a mechanism other than endothelial damage,
such as a prothrombotic effect or an increased susceptibility
to other atherogenic face.ors .
CELERMAJER ET AL .
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Noninvasive method . The development of a noninvasive
technique for the study of endothelial and smooth muscle
function permits study of a variety of groups at risk for
atherosclerosis. Phantom experiments (see Methods) and in
vivo studies (12,28-30) have shown that arterial diameter
Lan be measured precisely with low interobserver error . This
method is suitable only for the study of superficial arteries
rather than study of coronary vessels . However, atheroscle-
rosis is a diffuse process, often following the same course in
the coronary and proximal femoral arteries (31) ; and endo-
thelial damage has been well documented in the brachial
circulation of subjects with risk factors for atherosclerosis
(32,33) .
Clinical implications . Children with homozygous homo-
cystinutia have impaired endothelial function in their sys-
temic arteries despite dietary and pharmacologic therapy .
More aggressive homocystine-lowering regimens or newer
agents may be required to retard the progression to athero-
sclerosis. In contrast, endothelial function was preserved in
the adults we studied with heterozygous homocystinuria .
Neither attempts to screen the general adult population for
mild byperhoniocystinemia nor the treatment of such het-
erozygotes with pyridoxine, folic acid, betaine or low
methionine diets seem justified on the basis of these data .
We thank David Spiegelhalter, PhD for statistical assistance and Mary Jane
Potter for assistance iii preparation of
this manuscript .
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